1 recruiting, 1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow RNA-Sequencing: new trials by email Literature Review of RNA-Sequencing trials Research Report on RNA-Sequencing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform Whole Genome Sequencing, RNA-Sequencing, Microbiome analysis - Triple Negative Breast Cancer | Recruiting | Vall d'Hebron Institute of Oncology | 100 | 2023-01-13 | 2023-06-23 | |
| Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas Fluvastatin, RNA-sequencing, Gene expression profiling - Malignant Melanoma | Early Phase 1 | Withdrawn | Case Comprehensive Cancer Center | 2020-11-06 | 2020-07-27 |
Melanoma (1) · Triple Negative Breast Neoplasms (1)
Case Comprehensive Cancer Center (1) · Vall d'Hebron Institute of Oncology (1)
Spain (1)
Wesley Yu, MD (1)